INCIDENCE OF CATARACTS AFTER SINGLE FRACTION TOTAL-BODY IRRADIATION - THE ROLE OF STEROIDS AND GRAFT-VERSUS-HOST DISEASE

被引:0
|
作者
HAMON, MD
GALE, RF
MACDONALD, ID
SMITH, OP
COLLIS, CH
SKEGGS, DBL
GANDHI, L
PRENTICE, HG
机构
[1] ROYAL FREE HOSP,DEPT HAEMATOL,POND ST,LONDON NW3 2QG,ENGLAND
[2] ROYAL FREE HOSP,DEPT RADIOTHERAPY,LONDON NW3 2QG,ENGLAND
[3] UNIV LONDON SCH MED,LONDON,ENGLAND
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Eighty-eight patients who received single fraction total body irradiation (sfTBI) as part of their conditioning for allogeneic BMT have been evaluated for the risk of cataract formation. Thirty-eight (43%) have developed cataracts; 11 required surgery. With 9.5-13.6 years follow-up (median 10.7 years), all 12 recipients of unmanipulated marrow allografts have developed cateracts; the actuarial risk of needing surgery was 32 (+/- 18%, 95% confidence intervals (Cl)). Ten of these 12 required high-dose steroids (prednisolone > 1 mg/kg/day) for the treatment of GVHD. Seventy-six patients received T cell-depleted allografts; 14 of 76 required post-transplant immunosuppression with high-dose steroids. With 1-9.4 years follow-up (median 5 years), the actuarial risk of cataract formation in T cell-depleted allograft recipients is 72% (+/- 52% CI), the actuarial risk for needing surgery is 20% (+/- 9% CI). Recipients of sfTBI and non-T cell-depleted allografts had a significantly greater risk of developing cataracts (p = 0.003, log rank test) and of needing surgery (p < 0.05, log rank test) than patients receiving T cell-depleted BM. Cataracts occurred more frequently in patients requiring post-transplant immunosuppression with steroids (relative risk 2.12, p < 0.01 log rank test).
引用
收藏
页码:233 / 236
页数:4
相关论文
共 50 条
  • [41] THE ROLE OF CYTOKINES IN GRAFT-VERSUS-HOST REACTIONS AND DISEASE
    JADUS, MR
    WEPSIC, HT
    BONE MARROW TRANSPLANTATION, 1992, 10 (01) : 1 - 14
  • [42] Role of gut microbiota in graft-versus-host disease
    Murphy, Stephen
    Nguyen, Vu H.
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1844 - 1856
  • [43] GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION
    不详
    LANCET, 1984, 1 (8375) : 491 - 492
  • [44] GRAFT-VERSUS-HOST DISEASE AFTER MULTIORGAN TRANSPLANTATION
    PIRENNE, J
    NAKHLEH, RE
    DUNN, DL
    JOURNAL OF SURGICAL RESEARCH, 1991, 50 (06) : 622 - 628
  • [45] Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation
    Salam, A
    Waer, M
    TRANSPLANTATION, 1996, 61 (05) : 826 - 830
  • [46] ROLE OF LYMPHOKINES IN THE INDUCTION OF GRAFT-VERSUS-HOST DISEASE
    NIEDERWIESER, D
    TROPPMAIER, J
    ADOLPH, G
    MARGREITER, R
    HUBER, C
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 131 - 132
  • [47] Role of dendritic cells in graft-versus-host disease
    Clark, FJ
    Chakraverty, R
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (04): : 601 - 616
  • [48] The role of cytokines in acute graft-versus-host disease
    Hill, GR
    Krenger, W
    Ferrara, JLM
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1997, 3 (04) : 257 - 265
  • [49] Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: Role of natural killer T cells
    Liu, Yin Ping
    Li, Zengqi
    Nador, Roland G.
    Strober, Samuel
    TRANSPLANTATION, 2008, 85 (04) : 607 - 614
  • [50] Graft-Versus-Host Disease After Pancreatic Transplantation
    Saffo, Saad
    Peng, Chengwei
    Kibbi, Nour
    Patel, Natalie
    Robert, Marie E.
    Adekolu, Evelyn
    Asch, William S.
    Sanchez, Mayra
    ACG CASE REPORTS JOURNAL, 2019, 6 (09)